Option Care Health, Inc. $OPCH Shares Purchased by Intech Investment Management LLC

Key Points

• Intech Investment Management LLC increased its stake in Option Care Health by 9.4%, holding a total of 120,192 shares valued at approximately $4.2 million.
• Analyst ratings for Option Care Health show a strong outlook, with an average rating of "Moderate Buy" and a target price of $35.75 from multiple brokerages.
• Company insiders have recently purchased a significant number of shares, indicating confidence in the business, with total insider purchases valued at over $1.6 million in the last quarter.

Intech Investment Management LLC raised its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 9.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 120,192 shares of the company's stock after purchasing an additional 10,368 shares during the period. Intech Investment Management LLC owned 0.07% of Option Care Health worth $4,201,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of OPCH. Ameriprise Financial Inc. grew its position in shares of Option Care Health by 4.3% during the fourth quarter. Ameriprise Financial Inc. now owns 193,702 shares of the company's stock worth $4,494,000 after acquiring an additional 7,922 shares during the last quarter. BNP Paribas Financial Markets purchased a new position in shares of Option Care Health during the fourth quarter worth approximately $1,311,000. Deutsche Bank AG grew its position in shares of Option Care Health by 8.5% during the fourth quarter. Deutsche Bank AG now owns 637,305 shares of the company's stock worth $14,785,000 after acquiring an additional 50,149 shares during the last quarter. D. E. Shaw & Co. Inc. purchased a new position in shares of Option Care Health during the fourth quarter worth approximately $4,657,000. Finally, Ensign Peak Advisors Inc grew its position in shares of Option Care Health by 7.2% during the fourth quarter. Ensign Peak Advisors Inc now owns 59,853 shares of the company's stock worth $1,389,000 after acquiring an additional 4,020 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Option Care Health

In other news, Director Timothy P. Sullivan purchased 20,000 shares of the business's stock in a transaction dated Thursday, August 21st. The stock was acquired at an average price of $27.51 per share, with a total value of $550,200.00. Following the purchase, the director directly owned 49,229 shares of the company's stock, valued at $1,354,289.79. This represents a 68.43% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the business's stock in a transaction that occurred on Wednesday, August 20th. The stock was purchased at an average cost of $27.15 per share, with a total value of $977,400.00. Following the purchase, the director directly owned 375,390 shares in the company, valued at $10,191,838.50. The trade was a 10.61% increase in their position. The disclosure for this purchase can be found here. Insiders bought 59,411 shares of company stock valued at $1,627,576 in the last 90 days. 0.64% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on OPCH. JMP Securities raised their target price on shares of Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research report on Thursday, July 31st. Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. Finally, Barrington Research reaffirmed an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a report on Thursday, July 10th. Eight research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, Option Care Health presently has an average rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Price Performance

Shares of NASDAQ OPCH traded up $0.41 during trading on Thursday, hitting $28.44. 702,956 shares of the company were exchanged, compared to its average volume of 1,843,092. The company has a market cap of $4.62 billion, a price-to-earnings ratio of 22.74, a PEG ratio of 1.68 and a beta of 0.82. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The firm's fifty day moving average price is $28.91 and its 200 day moving average price is $31.33. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.40 by $0.01. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business's revenue was up 15.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, sell-side analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.